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Intrinsic expression of Th2 cytokines in urothelium of congen-
ital ureteropelvic junction obstruction.
Background. The cytokine-producing ability of urothelium,
a urinary tract barrier between urine and underlying con-
nective tissue, may exacerbate the pathogenesis of congenital
ureteropelvic junction obstruction (UPJ-O) disease. A role for
urothelium in human urinary tract obstruction has rarely been
described. In this study, we investigated the immunopathologic
characteristics of, and cytokine production by, urothelium in
children with congenital UPJ-O.
Methods. Twenty-four children with congenital UPJ-O who
had received pyeloplasty were enrolled. Morphologic ab-
normalities and pathologic and inflammatory changes of
UPJ-O segments were studied. Expression of cytokines and
chemokines in urothelium was investigated and compared with
control tissue by immunohistochemistry (IHC), in situ hy-
bridization (ISH), and urinary enzyme-linked immunosorbent
assay (ELISA).
Results. Atypical or simple hyperplasia of the urothelium
with evidence of Ki67 over-expression was found frequently in
UPJ-O. There were variable degrees of inflammatory cell and
eosinophil infiltration. Augmented expression of IL-5 and eo-
taxin detected by IHC and ISH, and enhanced degranulation
of tissue mast cells were observed in the urothelium of UPJ-O
segments. IL-4, IFN-c, and TNF-a were undetectable. Signif-
icantly higher levels of urinary IL-5, IFN-c, and eotaxin were
detected in urine collected from the obstructed kidney. Among
these, high urinary IL5 and/or IFN-c levels were associated with
more severe obstructive uropathy (P < 0.05).
Conclusion. Urothelium, like intestinal and respiratory ep-
ithelia, plays an active role in immunoregulation and may
contribute to exacerbation of the pathogenesis of congenital
UPJ-O. Many eosinophil-associated disease cytokines, which
can lead to the degranulation of mast cells, are predominant
regulators in UPJ-O urothelium.
Congenital urinary tract obstruction, with an incidence
of up to 1% of all pregnancies, is the most common fe-
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tal anomaly identified in antenatal screening of preg-
nant women. Among these lesions, ureteropelvic junc-
tion obstruction (UPJ-O) is the most common finding [1].
Obstructive uropathy, as a broad category, is also the ma-
jor etiology of chronic renal failure during infancy and
childhood [2, 3]. The clinical disease entity of UPJ-O may
not be a static lesion, but instead a dynamic and evolv-
ing process. The London group has shown that among
the 27% of children with prenatally detected dilatation
and differential function of 99m-technetium diethylen-
etriaminepentaacetic acid (DTPA), more than 40%
eventually required surgery for loss of function or devel-
opment of symptoms [4]. A previous report demonstrated
that nonobstructive prenatal hydronephrosis might later
convert to obstruction at the UPJ or in the juxtavesi-
cal ureter [5]. Fibrosis of the mucosa and fibromuscularis
tunicae along with changes in the number, distribution,
and size of the smooth muscle cells in the ureteral wall
are the main histologic abnormalities in UPJ-O [6, 7].
In animals, urothelium hyperplasia was also found in ex-
perimental hydronephrosis and pyelonephritis [8, 9]. It
has not been well documented in humans, except for the
study of Tadros et al, who showed heterogeneity of cy-
tokine alterations in urothelium of UPJ-O [10]. These
data indicate an association between urothelial changes
and UPJ-O; however, very little is known about the role
of urothelium in UPJ-O.
The local milieu, particularly the epithelia, may de-
termine whether stimuli encountered at the body sur-
faces lead to immune tolerance or activation [11]. It has
been reported that epithelial cells adjacent to a transi-
tional cell carcinoma may undergo hyperplastic changes
due to paracrine regulation by tumor-derived growth fac-
tors [12], raising the possibility that the local microenvi-
ronment may cause a urothelial reaction. Many in vivo
and in vitro studies [13–15] have shown that epithelia
may secrete cytokines and chemokines, particularly dur-
ing an allergic response [16]. However, the secretion of
cytokines and chemokines in urothelium has not been
well addressed. In addition, whether an allergy-like im-
mune reaction is present in urothelium has not been
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documented. In this study, we observed that in addition to
mononuclear cell infiltration, eosinophil infiltration was
frequently found in UPJ-O tissue. We therefore hypoth-
esized that urothelial reaction in UPJ-O might be caused
by an allergy-like immunoregulatory reaction. This study
was carried out to elucidate the involvement of immune
responses in the urothelium of UPJ-O. The results of this
study may shed light on the pathogenesis of ureteropelvic
junction obstruction.
METHODS
Inclusion criteria for patients
This prospective study was designed for all children
who were evaluated for hydronephrosis and were ad-
mitted to our medical center during the five-year period
ending December 31, 2000. Children with vesico-ureteric
junction obstruction, vesico-ureteric reflux, infravesical
obstruction, renal dysplasia, or external compression–
related hydronephrosis were excluded from the study.
Patients with congenital unilateral UPJ-O confirmed by
an antegrade pyelogram, and who had received percuta-
neous nephrostomy (PCN), Whitaker test, and dismem-
bered pyeloplasty were included. The function of the
obstructed side kidney was evaluated by DTPA diuretic
renogram. Renal sonography showed normal size and
contour for the contralateral kidneys of all patients. Sur-
gical indications were symptomatic presentation, thin-
ning cortical thickness, grade 4 hydronephrosis by renal
echography [17], relative pressure of Whitaker test >20
cmH2O, and a DTPA clearance half-time (t(1/2)) >20 min-
utes [18]. Our institutional review board approved the
study protocol. The objectives and details of our study
were explained to parents and to patients old enough
to understand. Parental approval was obtained before
performing pyeloplasty. According to the renal function
of the initial DTPA test, children with results in the ob-
structed kidney >40% were classified as group I (good
function); those with results ≤40% were put in group II
(poor function) as we did in our previous study [19].
Measurement of urine cytokines and chemokines
by ELISA
Split urine samples were collected from patients when
they had received a PCN to temporarily relieve pressure
on the obstructed side. To measure urinary cytokines
and chemokines, urine samples collected through the
nephrostomy tube were designated as the study group.
Urine samples collected via catheterization of the blad-
der were designated as the control group. All samples
were frozen at −70◦C until biochemical examinations
were performed, and all were lyophilized and reconsti-
tuted before analysis. Urinary cytokines and chemokines
were assessed for each specimen. Commercially avail-
able, sensitive, sandwich ELISA kits were used to de-
tect IFN-c (Endogen, Boston, MA, USA), TNF-a (R&D
Systems, Minneapolis, MN, USA), IL-4 (Endogen), IL-
5 (Endogen), and eotaxin (R&D Systems). The levels
of urinary cytokines and chemokines were divided by
the creatinine level and expressed as pg × 102/mg. All
procedures were carried out according to the manufac-
turers’ instructions. All ELISA results were duplicated
with relative coefficients >0.99 for each assay. The min-
imal detectable concentration was 10.2 pg/mL for IL-4,
10.2 pg/mL for IL-5, 25.6 pg/mL for IFN-c, 5 pg/mL for
eotaxin, and 4.4 pg/mL for TNF-a.
Routine histology and immunohistochemistry (IHC)
for tissue cytokines and chemokines
All UPJ-O specimens were obtained at the time of dis-
membered pyeloplasty and fixed in 10% buffered forma-
lin. Additionally, eight UPJ-O segment specimens were
immediately snap frozen in Tissue-Tek optimum cutting
temperature compound (Sakura Finetek, Torrance, CA,
USA). Routine histologic hematoxylin and eosin (H&E;
Sigma-Aldrich, St. Louis, MO, USA) stains were pre-
pared for each specimen. Additionally, IHC was per-
formed according to standard procedures for anti-Ki67
antibody (1:20; Immunotech, Marseille Cedex, France,
an assay measuring proliferation), cytokines (IFN-c
1:100, TNF-a 1:50, IL-4 1:25, IL-5 1:50; R&D Systems),
and mast cell tryptase (1:400; Dako, Carpinteria, CA,
USA). Eotaxin-2 antibody was suitable only for frozen
specimens (1:10; R&D Systems). Immunohistochemical
staining of human mast cell tryptase was used to
evaluate the activation of mast cells. Immunoreactive
target proteins were detected by polyclonal or mono-
clonal antibodies with the avidin-biotin immunoperox-
idase method (Ultratech HRP streptavidin-biotin detec-
tion kit; Immunotech), according to the manufacturer’s
instructions, overnight at 4◦C in a humidified chamber.
Diaminobenzidine (DAB) or 3-amino-9-ethylcarbazole
(AEC; Dako) was used as a chromogen and counter-
stained with methylene green (Sigma-Aldrich) or hema-
toxylin (Sigma-Aldrich).
In situ hybridization of tissue cytokines and chemokines
The cDNA probes for IFN-c, IL-4, IL-5, eotaxin, and
the Alu gene used for in situ hybridization (ISH) were
purchased from Maxim Biotech (South San Francisco,
CA, USA). In brief, biotinylated probes for cytokines,
chemokines, and the human housekeeping gene Alu were
produced by a polymerase chain reaction assay using
cDNA and biotin dATPs. For ISH, the concentrations
of each cDNA probe were IFN-c 2 lg/mL, IL-4 1 lg/mL,
IL-5 1 lg/mL, eotaxin 4 lg/mL, and the Alu gene 2 lg/mL.
Results were considered adequate if a probe generated
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Table 1. Pathologic characteristics of UPJ-O segments
Grade
Pathologic characteristic Grade 1 Grade 2 Grade 3 Grade 4
Inflammatory cell infiltration 0 2 12 6
Eosinophil infiltration 8 7 2 3
Urothelium hyperplasia 8 6 3 3
Urothelium degeneration 0 6 8 6
Submucosa collagen deposition 2 4 10 4
Muscular hypertrophy 0 11 9
Classification was based on a modification of the grading system of Zhang
et al [7]. Inflammatory cell infiltration—grade 1: no or rare inflammatory cells;
grade 2: mild inflammation (>15 but <30 inflammatory cells per high-power
field [×200]); grade 3: moderate inflammation (≥30 but <60 inflammatory cells
per high-power field); grade 4: severe inflammation (≥60 inflammatory cells
per high-power field). Eosinophil infiltration—grade 1: no eosinophils; grade
2: mild eosinophil infiltration (>0 but <10 eosinophils per high-power field
[×200]); grade 3: moderate eosinophil infiltration (≥10 but <30 eosinophils per
high-power field); grade 4: severe eosinophil infiltration (≥30 eosinophils per
high-power field). Urothelium hyperplasia—grade 1: no urothelium thickening
or layers of urothelium <6 layers; grade 2: mild thickening or layers of
urothelium >6 but ≤10 layers; grade 3: focal or diffuse moderate thickening
or layers >10 layers but ≤15 layers; grade 4: focal or diffuse severe thickening
or layers >15 layers. Urothelium degeneration as large clear cytoplasmic
vacuoles or eccentrically located pyknotic nuclei and/or dysplastic change (loss
of polarity, large nuclear to cytoplasmic ratio)—grade 1: normal morphology of
urothelium; grade 2: mild abnormal morphology; grade 3: moderate abnormal
morphology; grade 4: severe abnormal morphology. Submucosa collagen
deposition—grade 1: no abnormality; grade 2: mild interstitial fibrosis; grade
3: moderate interstitial fibrosis; grade 4: severe interstitial fibrosis. Muscular
hypertrophy (thickness)—grade 1: <0.2 mm; grade 2: 0.4 to 0.8 mm; grade 3:
>0.8 mm.
positive findings in positive control tissues, but failed in
negative control tissues.
In brief, we processed slides for ISH after the probes
were denatured at 95◦C for 5 minutes, according to
the manufacturer’s instructions (Maxim Biotech), with
a modification. Instead of linker-2, we used fluorescein
isothiocyanate (FITC) labeled antimouse antibody for
eotaxin, which was then analyzed with immunofluores-
cence microscopy.
Measurement procedures and methods
Positive and negative control slides for IHC and ISH
were processed simultaneously using the following pos-
itive controls: (1) tonsils of chronic tonsillitis for IFN-c,
TNF-a; and (2) turbinate mucosa of allergic rhinitis for
IL-4, IL-5, eotaxin, and mast cells. We had five cases
that were suitable nonobstructed controls for the UPJ:
UPJ segment tissues from children with Wilms’ tumor
that showed no evidence of obstruction. In addition, four
frozen ureter segments from below the stenotic segments
of UPJ-O patients were used for comparison. ISH with-
out target cDNA probes was performed as a negative
control.
Pathologic evaluation of the UPJ specimens was based
on the H&E stains and examined targets using a grading
system modified from that of Zhang, et al [7] (Table 1).
For quantitative analysis of the IHC findings, we adopted
a published method for morphometric analyses [20–22],
and the tissue images were captured with Image-Pro plus
software (version 4.51; Media Cybernetics, Silver Springs,
MD, USA). The density of each dot in the image was in-
dicated by digits according to a 36-bit color scale in which
white = 0 and black = 4095. Each slide with an IHC find-
ing was evaluated for foci from nonoverlapping micro-
scopic findings of 10 high-power fields (HPF), and inte-
grated optical density (×106) was calculated for grades of
severity. We counted nuclear Ki67 stains as a percentage
of positive cellular staining. Mast cell tryptase was evalu-
ated as the number of total mast cells and activated mast
cells appearing as swollen in size and/or degranulated for
foci from nonoverlapping microscopic finding of 10 HPF.
The negative control group was processed as above. A
negative result indicates the absence of antibody stain-
ing in nonstenotic UPJ segment tissue, or tissue below
the stenotic UPJ-O segment. For ISH, however, findings
were compared between study and control groups only.
Statistical analysis
Statistical analysis was done with a commercially
available computer software package (StatView 5.01;
Abacus Concepts, Inc., Berkeley, CA, USA). Unless in-
dicated otherwise, continuous variables were expressed
as mean ± standard error of the mean (SEM). When two
groups were compared, the Mann-Whitney test or chi-
square test, depending on whether the data were continu-
ous or categorical, was performed initially to confirm the
presence of significant differences. Paired ELISA data
between the UPJ-obstructed-side kidney and the con-
tralateral normal-side were analyzed using the Wilcoxon
signed rank test. Statistically significant differences be-
tween groups were defined as P < 0.05, and are indicated
in the text.
RESULTS
Twenty-four children, 16 boys (age range, 1 to 120
months; mean, 13.3 months; median, 1.5 months) and 8
girls (age range, 4 to 180 months; mean, 71.0 months;
median, 62.5 months) were enrolled in the study. Eight
children presented with abdominal pain. Five of the seven
children presenting with a urinary tract infection (UTI)
had been prenatally diagnosed with hydronephrosis. Al-
though 15 infants were suspected to have UPJ-O based
on prenatal sonography, only 14 (12 male and 2 female)
of them were diagnosed at or before six months of age
with UPJ-O. Twenty-four patients underwent a DTPA
test before they had pyeloplasty. Based on the radionu-
clide renal function test on the obstructed side, 15 patients
(11 boys, 4 girls; age 21.8 ± 9.7 months; median: 4.0
months) were placed in group I (DTPA: 48.3 ± 1.1%)
and 9 patients (5 boys, 4 girls; age 50.4 ± 22.5 months;
median: 5.0 months) in group II (29.2 ± 2.3%).
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After excluding inadequate samples, 20 tissue seg-
ments of obstructed UPJs were collected, and the char-
acteristics of pathologic presentation were analyzed.
Urothelium hyperplasia with infiltration of mononuclear
cells and eosinophils in UPJ-O tissue
Normally, three to six layers of transitional epithelium
over the human ureter (Fig. 1A) are present. Patho-
logic findings of the UPJ-O specimens demonstrated
a marked epithelial cell thickening in our subjects be-
cause the transitional urothelium frequently exceeded
six layers (60.0%, 12/20) (Table 1; Fig. 1B and C). In a
few samples, focal or diffuse urothelial cells exhibited
very large, single, clear vacuoles with eccentrically lo-
cated pyknotic nuclei, indicative of degenerative changes
(Fig. 1B). We observed marked interstitial collagen de-
position or matrix edema (90%, 18/20) in the subep-
ithelial lamina propria. Most remarkably, mononuclear
cells (100%) and eosinophils (60%, 12/20) infiltrated the
epithelium and lamina propria and, in some cases, the
smooth muscular layer (Fig. 1B and D). To rule out the
possibility of an overestimation of urothelial layers due to
tangential section, Ki67 staining was performed to clarify
the state of urothelial proliferation. The nonobstructed
UPJ segments showed negative or occasional staining of
Ki67 (Fig. 1E), while all the obstructed UPJ specimens
exhibited marked nuclear Ki67 staining, particularly in
urothelial and infiltrating cells (Fig. 1F). The percent-
age of cells showing Ki67 staining in the urothelium of
congenital UPJ-O segments and control nonobstructed
tissue was 21.4 ± 6.2% and 0.3 ± 0.1%, respectively
(Fig. 1, graph; P < 0.01). Although the percentage of Ki67
staining does not correlate with the severity of urothelial
hyperplasia (data not shown), our results indicate that
urothelial hyperplasia with mononuclear and eosinophil
infiltration is a prominent finding in UPJ-O. Because a
urinary tract infection induces inflammatory cell infiltra-
tion, seven patients with a history of urinary tract infec-
tions were excluded to avoid skewing the data.
Expression of Th1 and Th2 cytokines in urothelium
of UPJ-O lesions
To determine whether cytokines and chemokines are
produced in situ in urothelium, we performed IHC
and ISH for cytokine and chemokine expression in the
urothelium of obstructed tissue segments. Transverse sec-
tions of the UPJ segments from controls and obstructed
children were prepared for this purpose. Negative or
weak staining of IFN-c was present in both obstructed
and nonobstructed segments (Fig. 2A and B). Moreover,
no IFN-c mRNA was detectable in the urothelium of
the control or obstructed segments (data not shown).
The expression of IFN-c mRNA detected in tonsils with
chronic tonsillitis served as a positive control (Fig. 2C).
We performed an immunohistochemical analysis of TNF-
a to determine whether TNF-a, another downstream cy-
tokine in the Th1 immune response, was involved in the
urothelial hyperplasia. The results were negative for the
obstructed segments, but positive for the tonsil samples
(Fig. 2D and E).
To further explore the pattern of Th2 immune re-
sponses, we studied the expression of IL-4, IL-5, and eo-
taxin in tissues. IL-4 was not detectable in the tissue of any
obstructed or nonobstructed UPJ segments, but was de-
tectable in the epithelium of the turbinate mucosa of chil-
dren with allergic rhinitis (Fig. 3A and B). In addition, the
ISH analysis showed negative expression of IL-4 mRNA
in urothelium, which was consistent with immunohisto-
chemical findings (Fig. 3C). Although IL-5 was not ex-
pressed in the control tissues (Fig. 3D), brown stains in
cytoplasm that represent IL-5 were frequently observed,
not only in the urothelium, but also in the inflammatory
cells and smooth muscle cells of tissues from children with
congenital UPJ-O (Fig. 3E). Computerized image anal-
ysis of the staining was used to quantify IL-5 expression
in the obstructed and nonobstructed control UPJ seg-
ments. The results showed that a higher level of IL-5 was
present in UPJ-O tissue (Fig. 3, graph). Moreover, IL5
mRNA was detected predominantly in urothelium cyto-
plasm from the basal to apical layers of the obstructed seg-
ment (Fig. 3F), but not in tissue from the nonobstructed
control group (data not shown). Because eotaxin and
eotaxin-2 are both potent, selective eosinophil chemoat-
tractants [23], we explored whether eotaxin-2 levels were
elevated in the urothelium of obstructed segments. All
eight frozen UPJ-O specimens showed higher eotaxin-
2 expression in urothelium and inflammatory cells
(Fig. 3H) than the control specimens did (Fig. 3G). In
addition, eotaxin mRNA was detected in the cytoplasm
of the urothelium in UPJ-O lesions (Fig. 3I), but not in
control tissues (data not shown). Expression of eotaxin
mRNA in nasal mucosa from allergic rhinitis was used
as a positive control (data not shown). Taken together,
the results suggest that Th2 immune cells may mediate
an allergy-like response in UPJ-O tissue.
Activation of mast cells in urothelium of UPJ
Mast cells are activated in allergic and other in-
flammatory responses. Mast cell tryptase staining of
inactivated mast cells revealed densely packed brown
cytoplasm within the lamina propria of nonobstructed
control tissues (Fig. 4A and B); however, significantly
increased migration within the muscularis mucosa and
degranulation of mast cells was found in the tissues of
obstructed segments (Fig. 4C and D). The number of ac-
tivated mast cells, as demonstrated by cellular swelling
and/or degranulation in tryptase staining, was higher in
the obstructed group than in the controls (47.8 ± 8.7 vs.
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Fig. 1. Characteristic features of urothelium
in a normal ureter and a congenitally ob-
structed ureteropelvic junction. (A) Normal
urothelium contains three to six layers of
epithelial cells over submucosa (×200). (B)
Obstructed segment from a five-month-old
girl displays a marked urothelial thicken-
ing with eosinophil and mononuclear infil-
tration (×100). Large urothelium with clear
vacuoles and eccentrically located pyknotic
nuclei are seen in the inset (×200). (C) Cells
with enhanced nuclear-to-cytoplasm ratios
are seen at the suprabasal layer of urothe-
lium. Eosinophil infiltration in the urothe-
lium is also visible (×200) (see also inset,
×1000). (D) UPJ-O segment exhibits edema-
tous changes of lamina propria and infiltra-
tion of eosinophils (see also inset, ×400) and
mononuclear inflammatory cells (×100). (E)
Little staining of Ki67 antigen in the con-
trol segment (×200). (F) Positive dark nu-
clear staining of Ki67 antigen in urothelium
in the obstructed segment (×40). The graph
shows percentage of Ki67-positive cells is sig-
nificantly higher in the obstructed segment
than in the control segment (21.4 ± 6.2% vs.
0.3 ± 0.1%, P < 0.01). (, obstructed UPJ seg-
ment; , control nonobstructed segment).
Fig. 2. Expression of protein and mRNA lev-
els of Th1-related cytokines or chemokines
in the urothelium of UPJ-O segments. (A)
Negative IHC staining of IFN-c protein in
non-UPJ-O tissue (hematoxylin counterstain;
×200) and in (B) UPJ-O segment tissue
(hematoxylin; ×100). (C) ISH shows deep
blue stained granules indicating IFN-c mRNA
expression in tonsils of chronic tonsillitis as a
positive control (eosin; ×1000). (D) Brown
cytoplasmic color indicates TNF-a protein
(hematoxylin; ×200) seen in a tonsil with
chronic tonsillitis as a positive control. (E)
Negative IHC staining of TNF-a in obstructed
segments (methyl green; ×200).
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Fig. 4. Activation of mast cells and distribu-
tion analysis in a congenitally obstructed UPJ
segment. (A) Few brown densely packed cy-
toplasmic tryptase stains within mast cells are
seen within the lamina propria, and smooth
muscle of the control segment (hematoxylin;
×100). (B) Magnification of (A) shows the
small and densely packed mast cells in tis-
sues (×200), (see also inset, ×400). (C)
Activation of mast cells is manifested by an
increased number of mast cells within hyper-
trophic smooth muscle, as well as mast cell
swelling and degranulation in the obstructed
segment (×100). (D) Magnification of (C)
shows the cellular swelling and degranulation
of mast cells in tissues (see also inset, ×400).
The graph shows quantitative analysis of mast
cell activation. No significant difference in
total mast cell number between obstructed
and control tissues (55.8 ± 6.0 vs. 45.7 ± 4.8,
P= 0.31); however, the difference in activated
mast cells between obstructed and control tis-
sues (47.8 ± 8.7 vs. 3.4 ± 1.5, P < 0.0001) is
significant. Black bar, total count of mast cell;
white bar, activated mast cell number.
3.4 ± 1.5, P < 0.0001; Fig. 4, graph). However, the differ-
ence in number of mast cells between UPJ-O and control
tissues was not statistically significant (55.8±6.0 vs. 45.7±
4.8, P = 0.31).
Elevation of urinary cytokines and chemokines
on the obstructed side
To determine whether urinary cytokine and chemokine
levels reflect their elevated expression in UPJ-O urothe-
lium, we collected urine from the percutaneous nephros-
←−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
Fig. 3. Detection of Th2-related cytokines or chemokines in the urothelium by IHC and ISH. (A) Strong positive (brown color) expression of IL-4
protein staining within the turbinate mucosa of allergic mucosa (methyl green; ×200), but (B) negative staining of IL-4 protein (methyl green; ×100)
and (C) mRNA within an obstructed segment (eosin; ×1000). (D) IL-5 protein staining is negative in the control segment (methyl green; ×200),
but (E) strong IL-5 staining is observed in the urothelium (see also inset, ×400) of obstructed segments and in smooth muscle or inflammatory
cells (methyl green; ×100). (F) Deep blue granules of positive IL-5 mRNA are present within the obstructed segment urothelium (eosin; ×1000).
(G) Negative expression of eotaxin-2 in urothelium of control tissue (hematoxylin; ×200). (H) Positive cytoplasmic staining of eotaxin-2 in the
urothelium of the obstructed segment is seen (hematoxylin; ×100) (see also inset, ×400). (I) Positive cytoplasmic eotaxin mRNA expression is also
observed in urothelium of the obstructed segment (FITC; ×1000). Quantitative analysis (graph) by integrated optical density (IOD, ×106) showed
a significant difference in IL-5 between obstructed and control segments (1.52 ± 0.17 vs. 0.03 ± 0.02, P < 0.01). (, obstructed UPJ segment; ,
control nonobstructed segment).
tomy drainage of the obstructed kidney and the con-
tralateral side kidney and tested for it for cytokines and
chemokines by ELISA assay. After excluding 10 infants
and children due to a urinary tract infection or incom-
plete collection, urine samples from 14 patients were
deemed adequate for cytokine analysis (Fig. 5). TNF-a
and IL-4 were undetectable in the urine collected from
obstructed and nonobstructed kidneys. Levels of urinary
IFN-c, however, were significantly higher in samples from
the obstructed-side kidneys than from the nonobstructed
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Fig. 5. Paired results for urinary cytokine and chemokine levels be-
tween obstructed and control kidneys. (A) IFN-c/Cr, 92.8 ± 25.2 pg
× 102/mg in the obstructed kidney and 36.0 ± 6.3 pg × 102/mg in the
control kidney, P < 0.05. (B) IL-5/Cr, 42.0 ± 8.3 pg × 102/mg in the
obstructed kidney and 5.1 ± 0.9 pg × 102/mg in the control kidney,
P < 0.0001. (C) Eotaxin/Cr, 99.7 ± 38.0 pg × 102/mg in the obstructed
kidney and 4.1 ± 2.8 pg × 102/mg in the control kidney, P < 0.005.
[, obstructed kidney; , contralateral nonobstructed (control) kidney;
N = 14].
contralateral kidneys (Fig. 5A), as were urinary IL-5
(Fig. 5B) and eotaxin (Fig. 5C) levels.
Meanwhile, we analyzed the initial results of DTPA
tests with reference to levels of cytokines, chemokines,
and Ki67 counts (Table 2). Both IFN-c/Cr and IL5/Cr
ratios were significantly higher in group II than in group
I subjects (155.2 ± 40.6 vs. 49.2 ± 7.8 pg × 102/mg; 61.3 ±
12.3 vs. 23.9 ± 3.2 pg × 102/mg, respectively), but there
Table 2. Comparisons of gender, age, urinary cytokines, mast cell,
and cellular proliferation between the different DTPA renal function
groups of pre-pyeloplasty
Initial renal scan
Group I (15) Group II (9) P
Sex (male:female) 11:4 5:4 0.37
Age months 21.8 ± 9.7 50.4 ± 22.5 0.17
IFN-c/Cr pg ×102/mg 49.2 ± 7.8 (7) 155.2 ± 40.6 (7) <0.05
IL5/Cr pg ×102/mg 23.9 ± 3.2 (7) 61.3 ± 12.3 (7) <0.05
Eotaxin/Cr pg ×102/mg 97.8 ± 58.7 (7) 101.6 ± 53.0 (7) 0.56
Number of mast cells/HPF 64.4 ± 10.5 (12) 64.0 ± 16.4 (8) 0.81
Activated mast cells % 49.5 ± 8.0 (12) 54.8 ± 13.9 (8) 0.94
Ki67/HPF 20.3 ± 7.8 (12) 14.1 ± 6.3 (8) 0.98
IFN, interferon; IL, interleukin.
were no significant differences in expression of eotaxin,
number of mast cells, activated mast cells, and staining
of Ki67. Because IFN-c was not expressed in urothelium,
we speculate that there was an insult to the kidney. In
addition, positive expression of IL5 in urothelium with
high urinary levels suggests an inflammatory process in
UPJ-O segments.
DISCUSSION
A role for epithelium in the pathogenesis of respi-
ratory or gastrointestinal diseases is accepted [14–16].
However, this factor has not received much attention in
genitourinary diseases, especially obstructive uropathy.
In this study, we demonstrated that a urothelium abnor-
mality was present in the tissue of obstructed uretero-
pelvic junctions, which was first described by Bartoli et al
[24]. Urothelial proliferation was confirmed by the pres-
ence of Ki67 antigen, which reacts with a human nuclear
cell proliferation-associated antigen, and provides an ob-
jective and reliable index of the proliferative state of cells
[25]. Epithelial hyperplasia, dysplasia, and degeneration
represent morphologic aberrations and are common as-
sociated findings in many carcinomas [26]. Until now, no
evidence substantiated a correlation between UPJ-O and
transitional cell tumor formation. Thus, we speculate that
urothelial hyperplasia or other abnormal morphologic
changes may arise from inflammatory immunologic re-
actions. Our findings, which are similar to those of Zhang
et al [7], describe a significant inflammatory component
present in the lamina propria of UPJ-O, thereby indi-
cating a chronic inflammatory reaction in the obstructed
zone. It would be interesting to investigate whether the
chronic inflammatory process at the UPJ-O is important
in exacerbating the pathogenesis of muscular hypertro-
phy and fibrogenesis.
We provided evidence of local cytokine and chemokine
production in the urothelium of children with congeni-
tal UPJ-O. Elevated levels of IL-5, eotaxin, and eotaxin-
2, but not IFN-c, TNF-a, or IL-4 were demonstrated.
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Despite negative staining of IFN-c in urothelium, urine
IFN-c levels were higher in the obstructed side kidney,
suggesting that IFN-c is produced in the urinary tract
above the obstructed segment. In contrast to IFN-c and
TNF-a, which reflect Th1-response activation, IL-4 and
IL-5 reflect Th2 activation [27]. In general, IL-4 is closely
related to the production of IgE, and IL-5 can facilitate
eosinophil infiltration, as shown in our data, and then
further induce epithelial proliferation [28]. Therefore, the
urothelium in the obstructed ureteropelvic junction could
be a pool for the cytokine network involved in tissue im-
mune modulation.
The association of UPJ-O with Th2 type inflammation
and eosinophil infiltration has not been documented pre-
viously. IL-4 and IL-5 are often jointly produced, but dis-
sociation between IL-4 and IL-5 production, as seen in
our study, can be selectively induced by different sources
of stimulation. Both in vitro and in vivo parasitic infes-
tations selectively increase IL-5 production in the pres-
ence of IL-2, but they do not increase IL-4 production
[29]. Naora et al [30], in an elegant experiment, observed
that phorbol ester, IL-1a, and forskolin stimulated IL-5
expression, whereas calcium ionophore stimulated IL-4
expression. These results indicate that the IL-4 and IL-5
genes are regulated differently. Because IL-5 plays a cen-
tral role in the pathogenesis of eosinophilic inflammation,
therapeutic approaches aimed at the inhibition of IL-5
production might be effective in controlling the clinical
conditions involved in eosinophil-mediated tissue inflam-
mation.
A role for epithelial cells as cytokine-producing cells
has been defined in recent years. Our results support
a role for cytokine or chemokine responses in urothe-
lium as a mucosal cytokine network, which leads to
mononuclear cell and eosinophil infiltration. Tissues
from obstructed segments consistently showed infil-
tration of mononuclear cells and various concentra-
tions of eosinophils. Eosinophils are tissue-infiltrating
leukocytes and develop under the influence of certain
cytokines, such as IL-3, IL-5, eotaxin, and GM-CSF
[31]. These cytokines, which stimulate eosinophils and
trigger their maturation, lead to increased migration
capability, longer survival time, and active mediator re-
lease. Consequently, TGF-a, IL-1, IL-4, IL-5, GM-CSF,
and IL-3 could be produced from eosinophils [32, 33].
Then, these eosinophil-generated cytokines along with
Th2 lymphocyte-generated cytokines form a delicate net-
work that could be involved in the progress of UPJ-O
pathogenesis. Eotaxins, which are mainly produced by
epithelial cells, are potent eosinophil-selective chemoat-
tractants [34]. They are potent initiators of respiratory
bursts, increased production of reactive oxygen species,
and actin polymerization in eosinophils with a biologi-
cal activity comparable to that of the complement frag-
ment, C5a, and platelet-activating factor [35, 36]. In
addition, eotaxins support the migration of mast cells
under certain experimental conditions in vitro [37]. This
is consistent with the findings of increased migration of
mast cells and degranulation within the mucosal and
fibromuscular coats in UPJ-O lesions. Histamine and
prostaglandins produced by mast cells could induce pro-
longed muscular spasms, which in turn increase the
intrapelvic pressure and aggravate the obstruction in
UPJ-O. Moreover, cytokines, chemokines, and lipid me-
diators released by mast cells could further initiate an in-
flammatory cascade [38]. For these reasons, we speculate
that an urothelial-mesenchymal trophic unit becomes ac-
tive and drives pathologic remodeling and smooth muscle
proliferation through complex cytokine interactions. Fur-
ther investigation of the immunopathologic features and
consequences of the eosinophilic inflammation in UPJ-O
should be valuable.
All UPJ-O segments from patients with investiga-
tion of urinary ELISA assay were examined. Although
we found significant differences between UPJ-O indices
and control tissues, no statistically significant associa-
tion between the pathologic characteristics and urinary
cytokines, chemokines, or cellular proliferation within
UPJ-O tissues was seen. We cannot completely explain
this discrepancy, but it indicates that UPJ-O is a hetero-
geneous condition that requires further investigation to
improve the management and prognosis of each case.
CONCLUSION
Mucosal surfaces are sites of antigenic exclusion,
antigenic sampling, and immune regulation. Our study
suggests that urothelial cells, similar to intestinal and
respiratory epithelial cells, might have an active role in
immunoregulation, and may contribute to the exacerba-
tion of congenital UPJ-O. Due to Zhang et al’s findings
[7], the pathologic changes of UPJ may not be distin-
guishable by intrinsic or extrinsic etiology. We cannot ex-
clude alternative explanations, including the possibility
that urinary obstruction or any type of tissue damage sec-
ondary to urinary obstruction may be the initiating event
that accounts for all the observable data. Nevertheless,
based on our findings, we speculate that in the initial pri-
mary urothelium break stage of UPJ-O, chemokines pro-
duced by the urothelium may be the chemoattractants for
leukocytes. These events may lead to further inflamma-
tory responses, such as inflammatory cell infiltration, mast
cell migration, and activation. Like the chronic allergic
inflammatory responses of the airway, the combination
of local cytokines, histamine, and prostaglandins triggers
epithelial aberration and prolonged muscular spasms.
Likewise, the combined effects of the urothelium and
leukocytes may establish a local cytokine environment
and lead to a self-amplifying process typical of chronic
inflammatory tissue. Detailed knowledge of the cytokine
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responses in the urothelium is necessary for a better un-
derstanding of the role of urothelial cellular reactions in
congenital UPJ-O. Our findings may provide the basis for
early intervention to prevent exacerbation of congenital
hydronephrosis in the future.
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